H.R. 4525 · 119th Congress
Right to FDA-Approved Medicines Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Not yet voted on. This bill is still a proposal: it hasn't reached a floor vote, and its text can change in committee or on the floor before any vote.
D
RossSponsor29 cosponsors · 29 D
D
Castor
LF
D
Fletcher
KS
D
Schrier
LT
D
Trahan
BW
D
Watson Coleman
SC
D
Cohen
JM
D
McClellan
NW
D
Williams
MS
D
Strickland
YC
D
Clarke
SD
D
DelBene
MS
D
Scanlon
VE
D
Escobar
TK
D
Kennedy
JB
D
Beatty
SE
D
Elfreth
GM
D
Meng
DT
D
Titus
TL
D
Lieu
SP
D
Peters
MV
D
Veasey
LF
D
Frankel
JJ
D
Johnson
MD
D
DeSaulnier
JH
D
Hayes
AM
D
McClain Delaney
AC
D
Craig
WBD
Bell
CD
D
Deluzio4 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill sets out statutory protections for an individual's right to access and a health care provider's right to provide medicines (i.e., drugs and biological products) approved by the Food and Drug Administration (FDA).
What it does: CRS summary · Introduced in House · Jul 17, 2025
Right to FDA-Approved Medicines Act
This bill sets out statutory protections for an individual's right to access and a health care provider's right to provide medicines (i.e., drugs and biological products) approved by the Food and Drug Administration (FDA).
Generally, the bill prohibits measures that single out and impede access to FDA-approved medicines and related information. However, a party may defend against a claim that a measure violates the bill's prohibitions by demonstrating, through clear and convincing evidence, that the measure significantly advances access to FDA-approved medicines and such access cannot be advanced through less restrictive means. The bill also specifies that the prohibition preempts inconsistent state and local laws and applies in spite of other federal laws, including the Religious Freedom Restoration Act of 1993.
The Department of Justice, individuals, or health care providers may bring a lawsuit to enforce this bill, and states are not immune from suits for violations.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Right to FDA-Approved Medicines Act
Latest action (Jul 17, 2025): Referred to the House Committee on Energy and Commerce.
Policy area: Health · Origin: House · Introduced: Jul 17, 2025
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.